Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
5/10
Growth Score
7/10
Valuation Score
2/10
Momentum Score
5/10
₹634 Cr
42.3
3.74
--
0
11.66 %
--
0 %
7.44
0
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Gennex Lab
| 69.54 | 79.02 | 75.06 | 265.38 | 57.82 | 54.38 | 25.42 |
|
BSE Healthcare
| 39.27 | 6.73 | 18.33 | 54.13 | 18.28 | 27.81 | 12.16 |
|
BSE Small Cap
| 33.94 | 6.13 | 10.57 | 52.01 | 26.84 | 34.69 | 17.79 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Gennex Lab
| 163.07 | -42.17 | 123.68 | 83.92 | -29.46 | -39.04 | -7.13 |
|
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
No Review & Analysis are available.
Our rating system has guided millions of investors in the past 20 years.
No Review & Analysis are available.
₹633.90 Cr
₹101.40 Cr
₹14.99 Cr
₹60.98 Cr
₹17.34 Cr
18.42%
High
₹7.51 - 29.00
₹1.00
22,74,47,674
BSE: 531739
Sangareddy, Telangana
www.gennexlab.com
Gennex Laboratories Limited engages in the manufacturing and selling of bulk drugs, intermediates, and biotech products in India and internationally. The company offers active pharmaceutical ingredients, including Guaifenesin; Methocarbamol;... Fluconazole; Phenazopyridine Hcl; Allopurinol; and Ketoconazole. Its pipeline products include Melitracen Hydrochloride; Flupentixol Di-Hydrochloride; Domperidone; Potassium Guaiacol Sulphonate; Mefenamic Acid; Melitracen; and Chlorphenesin. The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India. Read more
The total asset value of Gennex Laboratories Ltd stood at ₹ 230 Cr as on 30-Jun-24
The share price of Gennex Laboratories Ltd is ₹28.50 (BSE) as of 19-Sep-2024 09:24 IST. Gennex Laboratories Ltd has given a return of 57.82% in the last 3 years.
Gennex Laboratories Ltd has a market capitalisation of ₹ 634 Cr as on 18-Sep-2024. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Gennex Laboratories Ltd is 42.30 times as on 18-Sep-2024.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Gennex Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Gennex Laboratories Ltd.
Gennex Laboratories Limited engages in the manufacturing and selling of bulk drugs, intermediates, and biotech products in India and internationally. The company offers active pharmaceutical ingredients, including Guaifenesin; Methocarbamol; Fluconazole; Phenazopyridine Hcl; Allopurinol; and Ketoconazole. Its pipeline products include Melitracen Hydrochloride; Flupentixol Di-Hydrochloride; Domperidone; Potassium Guaiacol Sulphonate; Mefenamic Acid; Melitracen; and Chlorphenesin. The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
The promoter of Gennex Laboratories Ltd is PREMIER FISCAL SERVICES PRIVATE LIMITED. PREMIER FISCAL SERVICES PRIVATE LIMITED owns 16.5 per cent of the total equity. The chairman of the company is , and the managing director is Arihant Baid..
There is no promoter pledging in Gennex Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
12,447
|
|
|
9,717
|
|
|
8,644
|
|
|
8,635
|
| Gennex Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
11.66
|
|
Operating margin(%)
|
16.64
|
|
Net Margin(%)
|
14.15
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Gennex Laboratories Ltd was ₹15 Cr.
₹0.63
